A 6-year-old child with β-thalassemia major is admitted to the pediatric unit for routine blood transfusion. Which assessment finding would be most concerning and require immediate nursing intervention?
The nurse is caring for a pediatric patient with β-thalassemia major who receives regular blood transfusions.
1Mild fatigue and pallor
2Splenomegaly on palpation
3Growth delay compared to peers
4Irregular heart rhythm with chest pain✓ 정답
해설
Children with β-thalassemia major require regular blood transfusions and are at risk for iron overload complications. Cardiac arrhythmias with chest pain indicate potential cardiac iron deposition, which can lead to cardiomyopathy and heart failure - a life-threatening complication requiring immediate intervention.
Core Nursing ExplanationKey Concept Analysis: This question assesses the ability to prioritize life-threatening complications in a patient with β-thalassemia major. The core pathophysiology involves chronic anemia requiring lifelong blood transfusions, which inevitably leads to iron overload (hemosiderosis). Excess iron deposits in vital organs, most critically the heart, liver, and endocrine glands. Cardiac iron deposition causes cardiomyopathy and electrical conduction disturbances, which are the leading cause of death in these patients.
Answer Rationale: Key Point! Option ④, "Irregular heart rhythm with chest pain," is the most concerning finding because it signals acute, potentially life-threatening cardiac involvement. An arrhythmia (irregular heart rhythm) can progress to fatal dysrhythmias like ventricular tachycardia or heart block. Chest pain may indicate myocardial ischemia or pericarditis. This represents an immediate threat to the patient's Airway, Breathing, Circulation (ABC) and requires urgent assessment, cardiac monitoring, and intervention.
Distractor Analysis:
Option ① (Mild fatigue and pallor): These are Watch out for confusion!chronic, baseline symptoms of the underlying anemia in β-thalassemia major. While they require monitoring and are addressed by the transfusion itself, they are not acute emergencies in a patient admitted for a routine transfusion.
Option ② (Splenomegaly on palpation): This is a common, expected finding due to extramedullary hematopoiesis (the body trying to make blood cells outside the bone marrow) and red blood cell sequestration. It is a chronic complication, not an immediate threat.
Option ③ (Growth delay compared to peers): This is a Watch out for confusion! long-term complication of iron overload affecting the pituitary gland and resulting in endocrine dysfunction (e.g., delayed puberty, short stature). It is significant for long-term management but does not require immediate intervention during this admission.
Related Concepts: The management of β-thalassemia major revolves around two main pillars: 1) Correcting anemia with transfusions, and 2) Preventing/treating iron overload with iron chelation therapy (e.g., deferoxamine, deferasirox). Nurses must monitor for signs of both complications of the disease (anemia, bone deformities) and complications of its treatment (transfusion reactions, chelator side effects, organ damage from iron).
Concept Summary
Concept
Description
Nursing Implication
β-Thalassemia Major
Genetic disorder causing severe deficiency in β-globin chain production, leading to chronic hemolytic anemia.
Lifelong transfusion dependence. Family education and genetic counseling are crucial.
Iron Overload (Hemosiderosis)
Primary complication of chronic transfusions. Iron deposits in heart, liver, endocrine glands.
Monitor for cardiac (arrhythmia, HF), hepatic (elevated LFTs), and endocrine (growth delay, diabetes) signs. Ensure adherence to chelation therapy.
Chelation Therapy
Medications (deferoxamine IV/SC, deferasirox oral) that bind excess iron for excretion.
Assess for side effects (hearing/vision loss with deferoxamine, renal/hepatic issues with deferasirox). Teach proper administration.
Extramedullary Hematopoiesis
Production of blood cells in spleen, liver, causing organomegaly and bone deformities.
Assess for splenomegaly/hepatomegaly. Monitor for signs of hypersplenism.
Side-by-Side Comparison!
Complication Type
Examples
Timeline / Urgency
Priority for Nursing Action
Acute / Life-Threatening
Cardiac arrhythmia, anaphylactic transfusion reaction, severe febrile non-hemolytic reaction, acute chest syndrome (in sickle cell, but a key differential).
Immediate (Minutes to Hours)
HIGHEST PRIORITY - Requires immediate assessment and intervention to preserve ABCs.
Chronic / Disease-Related
Growth delay, pallor, fatigue, splenomegaly, bone deformities (chipmunk facies).
Long-term (Months to Years)
Important for comprehensive care planning, patient education, and monitoring, but not an immediate emergency during a routine visit.
Chronic / Treatment-Related
Iron overload (all organ damage), infection risk from transfusions, alloimmunization.
Long-term (Years)
Prevention and surveillance are key. Requires diligent monitoring and teaching about chelation therapy adherence.
Anatomy, Physiology & Pharmacology Points
Pathophysiology: Defective β-globin synthesis → Unpaired α-globin chains precipitate in RBC precursors (ineffective erythropoiesis) and in mature RBCs (hemolysis) → Severe anemia.
Cardiac Toxicity: Iron deposits in the myocardium generate free radicals via the Fenton reaction, causing lipid peroxidation and cell damage, leading to dilated cardiomyopathy and conduction defects.
Pharmacology - Iron Chelators:
Deferoxamine: Binds iron in a 1:1 ratio. Given via slow subcutaneous infusion over 8-12 hours or IV. Side effects: Otic/ocular toxicity, anaphylaxis, pulmonary toxicity.
Deferasirox: Oral chelator. Monitor for creatinine (renal) and liver enzymes (hepatic) elevation.
Memory Tips
Think "Iron Heart": The biggest danger from iron overload is in the Heart. Cardiac complications are the #1 cause of death.
Acute vs. Chronic Mnemonic (A-CUTE):Arrhythmia, Chest pain = Urgent, Threatening, Emergency. Chronic symptoms like Fatigue, Growth delay, Splenomegaly are For General Surveillance (F-G-S).
Transfusion Goal in Thalassemia: Maintain a pre-transfusion hemoglobin level above 9-10 g/dL to suppress the body's own ineffective erythropoiesis and prevent bone deformities.
High-Frequency NCLEX Topics
This scenario tests prioritization and complication recognition, which are central to the NCLEX-RN. You must distinguish between expected chronic findings and new, acute, life-threatening symptoms. The exam often pairs chronic conditions (like thalassemia, sickle cell, cystic fibrosis) with an acute exacerbation or complication, asking you to identify the finding that requires immediate action.
Watch Out for Question Variations!
Shift from Symptom to Intervention: "The child with β-thalassemia major reports chest pain and palpitations. Which action should the nurse take first?" (Answer: Apply oxygen and attach cardiac monitor / Notify the physician immediately).
Shift to Medication Focus: "A patient with β-thalassemia major on deferoxamine infusion reports difficulty hearing. What is the nurse's best action?" (Answer: Stop the infusion and notify the provider – possible ototoxicity).
Shift to Patient Education: "The nurse is teaching the parents of a child with β-thalassemia major about iron chelation therapy. Which statement by a parent indicates a need for further teaching?" (Look for statements minimizing the importance of daily chelation or misunderstanding side effects).
Nursing Clinical Practice GuideClinical Scenario: You are the nurse on a pediatric hematology unit. Marco, a 7-year-old with β-thalassemia major, is here for his monthly packed red blood cell (PRBC) transfusion. During your pre-transfusion assessment, he says, "My heart feels funny, like it's skipping beats," and points to his chest, saying it hurts a little when he breathes deeply. His mother mentions he's been more tired than usual this week, even for him.
Nursing Intervention Strategy:
Immediate Assessment (ABCs):
Airway & Breathing: Assess respiratory rate, effort, oxygen saturation. Apply supplemental oxygen via nasal cannula if saturations are < 95%.
Circulation: This is the priority. Key Point!Attach to a cardiac monitor immediately. Assess heart rate, rhythm, and blood pressure. Palpate pulses. Note any irregularity. A 12-lead EKG should be obtained stat.
Pain: Use a pediatric pain scale to assess chest pain characteristics (location, intensity, quality, radiation).
Communication & Collaboration: Notify the pediatric hematologist and/or charge nurse immediately of the new cardiac symptoms. Do not proceed with the scheduled transfusion until the patient is evaluated. The transfusion itself could exacerbate cardiac strain if there is underlying heart failure.
Monitoring & Diagnostics: Assist with obtaining stat labs: Serum ferritin (to gauge iron load), cardiac enzymes (troponin), BNP (brain natriuretic peptide), and electrolytes. Prepare for a possible echocardiogram to assess cardiac function.
Comfort & Education: Keep Marco calm and explain procedures in age-appropriate terms. Reassure the parent while being honest about the need for urgent evaluation. Educate them that cardiac symptoms are a serious but known risk of iron overload, emphasizing why daily chelation therapy is so critical.
Patient Safety and Precautions:
Transfusion Caution: Administering a blood transfusion to a patient with suspected cardiac iron overload requires extreme caution. The increased blood volume can precipitate or worsen heart failure. Transfusions must be given slowly, and the patient must be monitored closely for signs of transfusion-associated circulatory overload (TACO) (e.g., dyspnea, crackles, hypertension).
Medication Review: Review the patient's chelation therapy regimen. Non-adherence is a common cause of accelerated iron overload. Assess for barriers to adherence.
Nursing Procedure & Medication FlowFor a Routine PRBC Transfusion in Thalassemia:
Pre-Transfusion: Verify order, consent, and crossmatch. Check vital signs as a baseline. Use two patient identifiers. Prime blood tubing with normal saline (0.9% NaCl).
Administration: Start transfusion slowly (e.g., 2-3 mL/kg/hr for the first 15-30 minutes). Stay with the patient for the first 15 minutes. Monitor vital signs per protocol (often at 15 min, 30 min, 1 hr, then hourly).
Monitoring for Reactions: Assess for fever, chills, itching, rash, respiratory distress, back pain, or hypotension.
Post-Transfusion: Document volume infused, patient tolerance, and post-transfusion vital signs. Flush line with saline.
Iron Chelation Administration (Example - Deferoxamine SC Infusion):
Reconstitute powder with sterile water. Draw up into a syringe for a syringe pump.
Use a small-gauge butterfly needle (e.g., 27-gauge) inserted subcutaneously, typically in the abdominal wall or thigh.
Program the pump to infuse over 8-12 hours, usually at night. Rotate sites daily to prevent lipohypertrophy.
Key Education: Teach parents/patient to monitor for signs of local reaction (redness, swelling) and systemic toxicity (hearing changes like tinnitus, vision changes like blurred vision).
A Word from Your Senior Nurse
Caring for patients with chronic, life-altering conditions like thalassemia is a marathon, not a sprint. Your role is to be their consistent advocate and educator. While managing the day-to-day fatigue and treatments, never let your guard down for the silent killer: iron in the heart. That subtle complaint of "my heart feels funny" or a slight irregularity on the monitor is your cue to spring into action. On the NCLEX and in practice, thinking "What can kill my patient right now?" is the lens through which you prioritize. In this case, the chronic pallor and fatigue are the background noise; the new chest pain and arrhythmia are the fire alarm. Listen for the alarm.
β-Thalassemia Major — A severe genetic form of thalassemia characterized by deficient or absent synthesis of the beta-globin chains of hemoglobin, leading to severe anemia, ineffective erythropoiesis, and hemolysis, requiring lifelong blood transfusions.
Iron Overload — A condition of excess total body iron, commonly resulting from chronic blood transfusions. Iron deposits in organs (heart, liver, endocrine glands), causing toxicity and organ dysfunction.
Chelation Therapy — Treatment using agents (chelators) that bind to excess metals (like iron) in the body, forming a complex that is excreted, thereby reducing the toxic accumulation. Examples include deferoxamine and deferasirox.
Extramedullary Hematopoiesis — The production of blood cells outside the bone marrow, occurring in the spleen, liver, and lymph nodes in response to severe chronic anemia. It leads to organomegaly (e.g., splenomegaly) and bone marrow expansion.
Transfusion-Associated Circulatory Overload — A transfusion reaction characterized by acute respiratory distress, hypertension, tachycardia, and pulmonary edema due to volume overload, particularly risky in patients with compromised cardiac function.